热门资讯> 正文
Terns Pharmaceuticals任命新首席财务官
2025-02-25 05:20
- Terns Pharmaceuticals (NASDAQ:TERN) announced the appointment of Andrew Gengos as chief financial officer, effective immediately.
- Gengos most recently, served as the chief financial officer of Athira Pharma (ATHA).
- Source: Press release
More on Terns Pharmaceuticals
- Terns Pharma: I Don't See The Positioning
- SA Asks: Which biotechs are most likely to be acquired near-term?
- Seeking Alpha’s Quant Rating on Terns Pharmaceuticals
- Historical earnings data for Terns Pharmaceuticals
- Financial information for Terns Pharmaceuticals
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。